Assembly Biosciences Inc.

NASDAQ: ASMB · Real-Time Price · USD
25.29
0.33 (1.32%)
At close: Aug 15, 2025, 3:59 PM
25.50
0.85%
Pre-market: Aug 18, 2025, 07:14 AM EDT

Assembly Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-40.18M -61.23M -93.09M -129.85M
Depreciation & Amortization
129K 450K 498K 466K
Stock-Based Compensation
3.12M 5.12M 6.59M 5.24M
Other Working Capital
-12.12M 77.47M -1.35M -6.25M
Other Non-Cash Items
-2.24M 9.21M 3.66M 44.69M
Deferred Income Tax
n/a -7.15M n/a -2.53M
Change in Working Capital
-11.95M 76.34M -2.12M -11.4M
Operating Cash Flow
-51.12M 22.74M -84.46M -93.4M
Capital Expenditures
-28K -255K -102K -3.1M
Cash Acquisitions
n/a n/a 1.5M 1.5M
Purchase of Investments
-94.16M -133.92M -27.58M -160.45M
Sales Maturities Of Investments
130.7M 65.02M 116.83M 187.7M
Other Investing Acitivies
3.66M 24K 90.74M 857K
Investing Cash Flow
40.17M -69.14M 90.64M 26.52M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a 129K 289K 258K
Financial Cash Flow
29.45M 13.82M 614K 53.06M
Net Cash Flow
18.5M -32.58M 6.79M -13.82M
Free Cash Flow
-51.15M 22.49M -84.56M -96.49M